Additional Analyses Needed to Optimize Treatment Efficacy, Sequencing in MM

This literature review investigated outcomes related to relapsed/refractory multiple myeloma (MM) among patients 65 years and older.

Related Keywords

,Cochrane Collaboration ,Mat Hayward ,Relapsed Refractory Multiple Myeloma ,Daratumumab ,Lenalidomide ,Dexamethasone ,